WASHINGTON — Vaccines, birth control pills, hormone therapies and fertility drugs would be subject to new litigation if the Supreme Court endorses a challenge to abortion pill mifepristone, pharmaceutical industry experts warn. When the court on Tuesday weighs whether to roll back Food and Drug Administration findings that made mifepristone more readily available, it is… Continue reading From IVF to birth control, Supreme Court abortion pill case could spark challenges to other drugs